Added to YB: 2020-09-16
Pitch date: 2020-09-16
GRF:SM [bullish]
Grifols, S.A.
-52.5%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.
Market Cap
EUR 6.7B
Pitch Price
EUR 23.48
Price Target
N/A
Dividend
2.72%
EV/EBITDA
9.86
P/E
20.19
EV/Sales
2.39
Sector
Biotechnology
Category
N/A
Show full summary:
GRIFOLS SA ORD A GRF:SM
A summary for this pitch has not been created yet.
Read full article (0 min)